These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 31281024)

  • 1. Waterjet Ablation Therapy for Treating Benign Prostatic Obstruction in Patients with Small- to Medium-size Glands: 12-month Results of the First French Aquablation Clinical Registry.
    Misrai V; Rijo E; Zorn KC; Barry-Delongchamps N; Descazeaud A
    Eur Urol; 2019 Nov; 76(5):667-675. PubMed ID: 31281024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Initial single centre experience of Aquablation of the prostate using the AquaBeam system with athermal haemostasis for the treatment of benign prostatic hyperplasia: 1-year outcomes.
    Whiting D; Ng KL; Barber N
    World J Urol; 2021 Aug; 39(8):3019-3024. PubMed ID: 33392647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aquablation - image-guided robot-assisted waterjet ablation of the prostate: initial clinical experience.
    Gilling P; Reuther R; Kahokehr A; Fraundorfer M
    BJU Int; 2016 Jun; 117(6):923-9. PubMed ID: 26477826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Waterjet Ablation Therapy for Endoscopic Resection of prostate tissue trial (WATER) vs WATER II: comparing Aquablation therapy for benign prostatic hyperplasia in 30-80 and 80-150 mL prostates.
    Nguyen DD; Barber N; Bidair M; Gilling P; Anderson P; Zorn KC; Badlani G; Humphreys M; Kaplan S; Kaufman R; So A; Paterson R; Goldenberg L; Elterman D; Desai M; Lingeman J; Roehrborn C; Bhojani N
    BJU Int; 2020 Jan; 125(1):112-122. PubMed ID: 31599044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostatic hydroablation (Aquablation): A new effective ultrasound guided robotic waterjet ablative surgery for treatment of benign prostatic hyperplasia.
    Lim Ng K; Barber N
    Arch Esp Urol; 2019 Oct; 72(8):786-793. PubMed ID: 31579037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aquablation therapy for symptomatic benign prostatic hyperplasia: a single-centre experience in 47 patients.
    Desai MM; Singh A; Abhishek S; Laddha A; Pandya H; Ashrafi AN; Ganpule AP; Roehrborn CG; Thomas AJ; Desai M; Sabnis RB
    BJU Int; 2018 Jun; 121(6):945-951. PubMed ID: 29319914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aquablation of the prostate for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia.
    Hwang EC; Jung JH; Borofsky M; Kim MH; Dahm P
    Cochrane Database Syst Rev; 2019 Feb; 2(2):CD013143. PubMed ID: 30759311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Five-year outcomes for Aquablation therapy compared to TURP: results from a double-blind, randomized trial in men with LUTS due to BPH.
    Gilling PJ; Barber N; Bidair M; Anderson P; Sutton M; Aho T; Kramolowsky E; Thomas A; Kaufman RP; Badlani G; Plante M; Desai M; Doumanian L; Te AE; Roehrborn CG
    Can J Urol; 2022 Feb; 29(1):10960-10968. PubMed ID: 35150215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aquablation of the prostate: single-center results of a non-selected, consecutive patient cohort.
    Bach T; Giannakis I; Bachmann A; Fiori C; Gomez-Sancha F; Herrmann TRW; Netsch C; Rieken M; Scoffone CM; Tunc L; Rassweiler JJ; Liatsikos E
    World J Urol; 2019 Jul; 37(7):1369-1375. PubMed ID: 30288598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of < 100 cc prostates and > 100 cc prostates undergoing aquablation for benign prostatic hyperplasia.
    Bhojani N; Nguyen DD; Kaufman RP; Elterman D; Zorn KC
    World J Urol; 2019 Jul; 37(7):1361-1368. PubMed ID: 30370457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Symptom relief and anejaculation after aquablation or transurethral resection of the prostate: subgroup analysis from a blinded randomized trial.
    Plante M; Gilling P; Barber N; Bidair M; Anderson P; Sutton M; Aho T; Kramolowsky E; Thomas A; Cowan B; Kaufman RP; Trainer A; Arther A; Badlani G; Desai M; Doumanian L; Te AE; DeGuenther M; Roehrborn C
    BJU Int; 2019 Apr; 123(4):651-660. PubMed ID: 29862630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of aquablation of the prostate for patients with symptomatic benign prostatic enlargement: a systematic review.
    Suarez-Ibarrola R; Bach T; Hein S; Cocci A; Russo GI; Herrmann TRW; Gratzke C; Miernik A
    World J Urol; 2020 May; 38(5):1147-1163. PubMed ID: 31559476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. WATER: A Double-Blind, Randomized, Controlled Trial of Aquablation
    Gilling P; Barber N; Bidair M; Anderson P; Sutton M; Aho T; Kramolowsky E; Thomas A; Cowan B; Kaufman RP; Trainer A; Arther A; Badlani G; Plante M; Desai M; Doumanian L; Te AE; DeGuenther M; Roehrborn C
    J Urol; 2018 May; 199(5):1252-1261. PubMed ID: 29360529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. WATER II (80-150 mL) procedural outcomes.
    Desai M; Bidair M; Bhojani N; Trainer A; Arther A; Kramolowsky E; Doumanian L; Elterman D; Kaufman RP; Lingeman J; Krambeck A; Eure G; Badlani G; Plante M; Uchio E; Gin G; Goldenberg L; Paterson R; So A; Humphreys M; Roehrborn C; Kaplan S; Motola J; Zorn KC
    BJU Int; 2019 Jan; 123(1):106-112. PubMed ID: 29694702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aquablation of the Prostate for Symptomatic Benign Prostatic Hyperplasia: 1-Year Results.
    Gilling P; Anderson P; Tan A
    J Urol; 2017 Jun; 197(6):1565-1572. PubMed ID: 28111300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two-Year Outcomes After Aquablation Compared to TURP: Efficacy and Ejaculatory Improvements Sustained.
    Gilling P; Barber N; Bidair M; Anderson P; Sutton M; Aho T; Kramolowsky E; Thomas A; Cowan B; Kaufman RP; Trainer A; Arther A; Badlani G; Plante M; Desai M; Doumanian L; Te AE; DeGuenther M; Roehrborn C
    Adv Ther; 2019 Jun; 36(6):1326-1336. PubMed ID: 31028614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aquablation versus transurethral resection of the prostate: 1 year United States - cohort outcomes.
    Kasivisvanathan V; Hussain M
    Can J Urol; 2018 Jun; 25(3):9317-9322. PubMed ID: 29900819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aquablation versus TURP: 5-year outcomes of the WATER randomized clinical trial for prostate volumes 50-80 mL.
    Oumedjbeur K; Corsi NJ; Bouhadana D; Ibrahim A; Nguyen DD; Matta I; Arezki A; Sadri I; Elsherbini T; Bhojani N; Elterman DS; Chughtai B; Helfand BT; Glaser AP; Misrai V; Kaplan S; Gilling P; Barber N; Desai M; Badlani GH; Te AE; Roehrborn CG; Zorn KC
    Can J Urol; 2023 Oct; 30(5):11650-11658. PubMed ID: 37838991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized Controlled Trial of Aquablation versus Transurethral Resection of the Prostate in Benign Prostatic Hyperplasia: One-year Outcomes.
    Gilling PJ; Barber N; Bidair M; Anderson P; Sutton M; Aho T; Kramolowsky E; Thomas A; Cowan B; Roehrborn C
    Urology; 2019 Mar; 125():169-173. PubMed ID: 30552937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ablative minimally invasive surgical therapies for benign prostatic hyperplasia: A review of Aquablation, Rezum, and transperineal laser prostate ablation.
    Nguyen DD; Li T; Ferreira R; Baker Berjaoui M; Nguyen AV; Chughtai B; Zorn KC; Bhojani N; Elterman D
    Prostate Cancer Prostatic Dis; 2024 Mar; 27(1):22-28. PubMed ID: 37081044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.